Regie Lyn Santos-Cortez
Concepts (386)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Otitis Media | 17 | 2025 | 178 | 8.780 |
Why?
| | Hearing Loss | 26 | 2023 | 177 | 5.230 |
Why?
| | Genes, Recessive | 27 | 2021 | 77 | 3.040 |
Why?
| | Mutation, Missense | 16 | 2024 | 331 | 2.740 |
Why?
| | Pedigree | 54 | 2025 | 507 | 2.650 |
Why?
| | Microbiota | 10 | 2023 | 724 | 2.390 |
Why?
| | alpha-Macroglobulins | 6 | 2024 | 24 | 2.390 |
Why?
| | Deafness | 7 | 2023 | 67 | 2.360 |
Why?
| | Genetic Variation | 12 | 2025 | 992 | 2.270 |
Why?
| | Ear, Middle | 8 | 2024 | 78 | 2.070 |
Why?
| | Genetic Predisposition to Disease | 25 | 2025 | 2455 | 2.030 |
Why?
| | Mutation | 27 | 2023 | 4082 | 1.680 |
Why?
| | Migraine Disorders | 2 | 2025 | 109 | 1.450 |
Why?
| | Consanguinity | 21 | 2024 | 50 | 1.270 |
Why?
| | Fucosyltransferases | 2 | 2022 | 31 | 1.250 |
Why?
| | Cochlear Implantation | 3 | 2021 | 74 | 1.230 |
Why?
| | Sequence Analysis, DNA | 16 | 2020 | 771 | 1.130 |
Why?
| | Cochlear Implants | 3 | 2020 | 86 | 1.110 |
Why?
| | Vertigo | 2 | 2025 | 40 | 1.050 |
Why?
| | RNA, Ribosomal, 16S | 5 | 2023 | 507 | 1.030 |
Why?
| | Membrane Proteins | 9 | 2021 | 1130 | 1.030 |
Why?
| | Exome | 17 | 2023 | 232 | 1.000 |
Why?
| | Gene Frequency | 8 | 2019 | 495 | 0.860 |
Why?
| | Vestibular Diseases | 1 | 2025 | 45 | 0.840 |
Why?
| | Nasopharynx | 2 | 2022 | 72 | 0.840 |
Why?
| | Palatine Tonsil | 1 | 2024 | 55 | 0.840 |
Why?
| | Herpesvirus 4, Human | 1 | 2024 | 172 | 0.790 |
Why?
| | Pakistan | 17 | 2024 | 83 | 0.780 |
Why?
| | Otitis Media, Suppurative | 2 | 2024 | 4 | 0.780 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2024 | 102 | 0.770 |
Why?
| | Meniere Disease | 1 | 2023 | 12 | 0.760 |
Why?
| | Intellectual Disability | 3 | 2023 | 178 | 0.760 |
Why?
| | Aortic Aneurysm, Thoracic | 8 | 2016 | 135 | 0.750 |
Why?
| | Alleles | 8 | 2019 | 900 | 0.730 |
Why?
| | Cholesteatoma | 1 | 2022 | 10 | 0.720 |
Why?
| | Child | 26 | 2025 | 22638 | 0.710 |
Why?
| | Cadherin Related Proteins | 1 | 2021 | 12 | 0.690 |
Why?
| | Haemophilus Infections | 1 | 2022 | 45 | 0.680 |
Why?
| | Genotype | 17 | 2023 | 1866 | 0.680 |
Why?
| | Down-Regulation | 2 | 2024 | 612 | 0.670 |
Why?
| | Connexins | 6 | 2016 | 54 | 0.670 |
Why?
| | Membrane Transport Proteins | 4 | 2017 | 153 | 0.660 |
Why?
| | Temporal Bone | 1 | 2021 | 43 | 0.650 |
Why?
| | Child, Preschool | 16 | 2025 | 11888 | 0.650 |
Why?
| | Serine Peptidase Inhibitor Kazal-Type 5 | 1 | 2020 | 3 | 0.640 |
Why?
| | Plasminogen | 1 | 2020 | 26 | 0.640 |
Why?
| | Mentoring | 1 | 2023 | 165 | 0.630 |
Why?
| | Male | 65 | 2025 | 73014 | 0.620 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2024 | 300 | 0.620 |
Why?
| | Scoliosis | 1 | 2023 | 230 | 0.620 |
Why?
| | Humans | 85 | 2025 | 145625 | 0.610 |
Why?
| | Otitis Media with Effusion | 1 | 2019 | 20 | 0.600 |
Why?
| | Female | 64 | 2025 | 79080 | 0.590 |
Why?
| | ABO Blood-Group System | 1 | 2019 | 56 | 0.580 |
Why?
| | Philippines | 5 | 2019 | 50 | 0.570 |
Why?
| | Genetic Markers | 3 | 2018 | 337 | 0.560 |
Why?
| | Gene Regulatory Networks | 1 | 2021 | 319 | 0.550 |
Why?
| | Mice, Knockout | 3 | 2024 | 3121 | 0.530 |
Why?
| | Mice | 15 | 2025 | 18266 | 0.530 |
Why?
| | Acid Ceramidase | 1 | 2017 | 2 | 0.520 |
Why?
| | Keloid | 1 | 2017 | 8 | 0.520 |
Why?
| | Albinism, Oculocutaneous | 1 | 2017 | 5 | 0.510 |
Why?
| | Ear, Inner | 3 | 2016 | 43 | 0.500 |
Why?
| | Homozygote | 9 | 2018 | 196 | 0.500 |
Why?
| | Genes, Duplicate | 1 | 2016 | 4 | 0.500 |
Why?
| | Down Syndrome | 1 | 2023 | 529 | 0.480 |
Why?
| | Receptors, Lysosphingolipid | 1 | 2016 | 13 | 0.470 |
Why?
| | Genetic Linkage | 13 | 2018 | 269 | 0.470 |
Why?
| | Hearing Loss, Sensorineural | 4 | 2021 | 66 | 0.460 |
Why?
| | Animals | 20 | 2025 | 38030 | 0.450 |
Why?
| | Adolescent | 21 | 2025 | 22451 | 0.440 |
Why?
| | DNA, Bacterial | 1 | 2016 | 319 | 0.440 |
Why?
| | Gene Duplication | 1 | 2015 | 67 | 0.440 |
Why?
| | Hair Cells, Auditory | 2 | 2021 | 44 | 0.440 |
Why?
| | Haplotypes | 8 | 2019 | 505 | 0.440 |
Why?
| | Neurodevelopmental Disorders | 1 | 2018 | 234 | 0.430 |
Why?
| | Phenotype | 14 | 2021 | 3186 | 0.400 |
Why?
| | Disease Models, Animal | 2 | 2024 | 4565 | 0.400 |
Why?
| | Adenylyl Cyclases | 1 | 2014 | 60 | 0.400 |
Why?
| | Lysine-tRNA Ligase | 1 | 2013 | 2 | 0.390 |
Why?
| | Lod Score | 11 | 2016 | 62 | 0.390 |
Why?
| | Cyclic AMP | 1 | 2014 | 208 | 0.380 |
Why?
| | Myosins | 3 | 2021 | 131 | 0.380 |
Why?
| | Genetic Loci | 6 | 2014 | 272 | 0.370 |
Why?
| | Chromosomes, Human, Pair 19 | 2 | 2016 | 27 | 0.360 |
Why?
| | Gene Expression Profiling | 1 | 2019 | 1790 | 0.350 |
Why?
| | Environmental Exposure | 1 | 2016 | 578 | 0.350 |
Why?
| | Retinitis Pigmentosa | 2 | 2023 | 21 | 0.340 |
Why?
| | Adult | 23 | 2024 | 40821 | 0.320 |
Why?
| | Otoscopy | 2 | 2023 | 8 | 0.310 |
Why?
| | Finland | 2 | 2019 | 72 | 0.300 |
Why?
| | Chromosomes, Human, Pair 4 | 2 | 2006 | 26 | 0.300 |
Why?
| | Polymorphism, Single Nucleotide | 7 | 2025 | 2228 | 0.290 |
Why?
| | Polydactyly | 2 | 2019 | 11 | 0.290 |
Why?
| | Genetic Association Studies | 6 | 2019 | 376 | 0.290 |
Why?
| | Family Health | 6 | 2019 | 192 | 0.290 |
Why?
| | Toes | 2 | 2019 | 16 | 0.290 |
Why?
| | Codon, Nonsense | 4 | 2018 | 45 | 0.290 |
Why?
| | Amino Acid Sequence | 9 | 2020 | 2088 | 0.280 |
Why?
| | Fingers | 2 | 2019 | 106 | 0.270 |
Why?
| | Ichthyosiform Erythroderma, Congenital | 3 | 2017 | 4 | 0.270 |
Why?
| | Genes, Dominant | 2 | 2011 | 94 | 0.260 |
Why?
| | Connexin 26 | 5 | 2014 | 9 | 0.250 |
Why?
| | Sequence Analysis, RNA | 2 | 2020 | 441 | 0.250 |
Why?
| | COS Cells | 2 | 2018 | 173 | 0.240 |
Why?
| | Mice, Inbred C57BL | 6 | 2021 | 6021 | 0.230 |
Why?
| | Logistic Models | 2 | 2025 | 2112 | 0.230 |
Why?
| | Genomics | 3 | 2020 | 851 | 0.230 |
Why?
| | Bacteria | 2 | 2022 | 766 | 0.220 |
Why?
| | Frameshift Mutation | 3 | 2015 | 31 | 0.220 |
Why?
| | Molecular Sequence Data | 7 | 2016 | 2835 | 0.220 |
Why?
| | Exons | 5 | 2018 | 361 | 0.220 |
Why?
| | Molecular Epidemiology | 1 | 2005 | 74 | 0.210 |
Why?
| | Case-Control Studies | 4 | 2025 | 3633 | 0.210 |
Why?
| | Cohort Studies | 5 | 2025 | 6045 | 0.210 |
Why?
| | Infant | 7 | 2021 | 10093 | 0.210 |
Why?
| | Dizziness | 1 | 2025 | 93 | 0.210 |
Why?
| | Serine Endopeptidases | 2 | 2018 | 129 | 0.210 |
Why?
| | Fasting | 1 | 2006 | 280 | 0.200 |
Why?
| | HEK293 Cells | 4 | 2023 | 746 | 0.200 |
Why?
| | Cochlea | 2 | 2015 | 63 | 0.200 |
Why?
| | Continuous Positive Airway Pressure | 1 | 2024 | 91 | 0.200 |
Why?
| | Models, Molecular | 4 | 2016 | 1571 | 0.190 |
Why?
| | Chromosome Mapping | 8 | 2019 | 505 | 0.190 |
Why?
| | Intracranial Aneurysm | 2 | 2016 | 105 | 0.190 |
Why?
| | Zebrafish | 4 | 2016 | 533 | 0.180 |
Why?
| | Faculty | 1 | 2023 | 151 | 0.180 |
Why?
| | Cross-Sectional Studies | 3 | 2025 | 5875 | 0.180 |
Why?
| | High-Throughput Nucleotide Sequencing | 5 | 2016 | 538 | 0.180 |
Why?
| | Extracellular Matrix Proteins | 1 | 2023 | 156 | 0.170 |
Why?
| | ADAMTS1 Protein | 1 | 2021 | 2 | 0.170 |
Why?
| | Carboxy-Lyases | 1 | 2021 | 10 | 0.170 |
Why?
| | Haemophilus influenzae | 1 | 2022 | 67 | 0.170 |
Why?
| | RNA Splice Sites | 2 | 2018 | 51 | 0.170 |
Why?
| | Mentors | 1 | 2023 | 215 | 0.170 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2019 | 456 | 0.160 |
Why?
| | Phosphoric Diester Hydrolases | 1 | 2021 | 53 | 0.160 |
Why?
| | Oncogene Proteins | 1 | 2021 | 61 | 0.160 |
Why?
| | Base Sequence | 2 | 2015 | 2119 | 0.160 |
Why?
| | Ear, External | 1 | 2020 | 22 | 0.160 |
Why?
| | DNA Demethylation | 1 | 2020 | 4 | 0.160 |
Why?
| | Mouth | 1 | 2020 | 84 | 0.150 |
Why?
| | Dioxygenases | 1 | 2020 | 36 | 0.150 |
Why?
| | Ichthyosis, Lamellar | 2 | 2017 | 7 | 0.150 |
Why?
| | Lipoxygenase | 2 | 2017 | 15 | 0.150 |
Why?
| | Chronic Disease | 2 | 2024 | 1824 | 0.150 |
Why?
| | Young Adult | 9 | 2020 | 14240 | 0.150 |
Why?
| | Nerve Tissue Proteins | 2 | 2021 | 594 | 0.150 |
Why?
| | Ciliopathies | 1 | 2018 | 6 | 0.140 |
Why?
| | Protein Conformation | 3 | 2020 | 914 | 0.140 |
Why?
| | Feasibility Studies | 1 | 2023 | 1125 | 0.140 |
Why?
| | Tumor Suppressor Proteins | 1 | 2021 | 314 | 0.140 |
Why?
| | Acute Disease | 2 | 2019 | 1033 | 0.140 |
Why?
| | Chromosome Segregation | 1 | 2018 | 46 | 0.140 |
Why?
| | Saliva | 1 | 2020 | 256 | 0.140 |
Why?
| | Disease Susceptibility | 1 | 2020 | 339 | 0.140 |
Why?
| | Arthrogryposis | 2 | 2015 | 17 | 0.140 |
Why?
| | Hypotrichosis | 1 | 2018 | 1 | 0.140 |
Why?
| | Genetic Diseases, Inborn | 1 | 2018 | 45 | 0.140 |
Why?
| | Ichthyosis | 1 | 2018 | 8 | 0.140 |
Why?
| | Polymorphism, Genetic | 3 | 2005 | 611 | 0.140 |
Why?
| | RNA Splicing Factors | 1 | 2018 | 66 | 0.130 |
Why?
| | Skin Diseases, Genetic | 1 | 2017 | 7 | 0.130 |
Why?
| | Nails, Malformed | 1 | 2017 | 5 | 0.130 |
Why?
| | 3' Untranslated Regions | 1 | 2018 | 152 | 0.130 |
Why?
| | Cytoskeletal Proteins | 2 | 2015 | 146 | 0.130 |
Why?
| | DEAD-box RNA Helicases | 1 | 2018 | 89 | 0.130 |
Why?
| | Middle Aged | 11 | 2020 | 36359 | 0.130 |
Why?
| | Optic Atrophy | 1 | 2016 | 8 | 0.120 |
Why?
| | Rare Diseases | 1 | 2017 | 115 | 0.120 |
Why?
| | Linkage Disequilibrium | 2 | 2016 | 257 | 0.120 |
Why?
| | Family | 2 | 2018 | 680 | 0.120 |
Why?
| | Developmental Disabilities | 1 | 2020 | 280 | 0.120 |
Why?
| | Oxidoreductases Acting on CH-CH Group Donors | 1 | 2016 | 27 | 0.120 |
Why?
| | Dystonic Disorders | 1 | 2016 | 27 | 0.120 |
Why?
| | Population Groups | 1 | 2016 | 55 | 0.120 |
Why?
| | Trichothiodystrophy Syndromes | 1 | 2016 | 1 | 0.120 |
Why?
| | Marfan Syndrome | 2 | 2016 | 44 | 0.120 |
Why?
| | Fibrillin-1 | 1 | 2016 | 6 | 0.120 |
Why?
| | Recurrence | 1 | 2019 | 1125 | 0.120 |
Why?
| | Integrin beta Chains | 1 | 2015 | 7 | 0.120 |
Why?
| | Protein-Lysine 6-Oxidase | 1 | 2016 | 14 | 0.120 |
Why?
| | Alopecia | 1 | 2015 | 33 | 0.120 |
Why?
| | Tooth Abnormalities | 1 | 2015 | 17 | 0.110 |
Why?
| | Keratins, Type I | 1 | 2015 | 1 | 0.110 |
Why?
| | Sphingosine | 1 | 2016 | 46 | 0.110 |
Why?
| | Hair Diseases | 1 | 2015 | 9 | 0.110 |
Why?
| | Activating Transcription Factor 6 | 1 | 2015 | 19 | 0.110 |
Why?
| | Autistic Disorder | 2 | 2020 | 215 | 0.110 |
Why?
| | Color Vision Defects | 1 | 2015 | 8 | 0.110 |
Why?
| | Coatomer Protein | 1 | 2015 | 3 | 0.110 |
Why?
| | Blood Glucose | 1 | 2006 | 2357 | 0.110 |
Why?
| | Mitral Valve Insufficiency | 1 | 2016 | 69 | 0.110 |
Why?
| | Precision Medicine | 1 | 2019 | 462 | 0.110 |
Why?
| | Lipase | 1 | 2015 | 76 | 0.110 |
Why?
| | Lysophospholipids | 1 | 2016 | 80 | 0.110 |
Why?
| | Methionine Adenosyltransferase | 1 | 2014 | 10 | 0.110 |
Why?
| | Transglutaminases | 1 | 2015 | 137 | 0.110 |
Why?
| | Muscle Hypotonia | 1 | 2015 | 34 | 0.110 |
Why?
| | Contracture | 1 | 2015 | 23 | 0.110 |
Why?
| | Hair | 1 | 2015 | 81 | 0.110 |
Why?
| | Golgi Apparatus | 1 | 2015 | 98 | 0.110 |
Why?
| | Chromosomes, Human, Pair 16 | 2 | 2014 | 36 | 0.110 |
Why?
| | Forkhead Transcription Factors | 1 | 2016 | 208 | 0.110 |
Why?
| | Sodium Channels | 1 | 2015 | 63 | 0.110 |
Why?
| | Autoantigens | 1 | 2017 | 426 | 0.110 |
Why?
| | Principal Component Analysis | 1 | 2015 | 192 | 0.110 |
Why?
| | Aortic Aneurysm, Abdominal | 1 | 2016 | 162 | 0.110 |
Why?
| | Moyamoya Disease | 1 | 2014 | 20 | 0.110 |
Why?
| | Transcriptome | 1 | 2021 | 1066 | 0.110 |
Why?
| | Prevalence | 2 | 2016 | 2852 | 0.100 |
Why?
| | Genetic Heterogeneity | 1 | 2014 | 66 | 0.100 |
Why?
| | Muscle, Smooth, Vascular | 2 | 2016 | 449 | 0.100 |
Why?
| | Labyrinth Supporting Cells | 1 | 2014 | 3 | 0.100 |
Why?
| | Arthritis | 1 | 2015 | 97 | 0.100 |
Why?
| | RNA Splicing | 1 | 2016 | 287 | 0.100 |
Why?
| | Extremities | 1 | 2015 | 142 | 0.100 |
Why?
| | Carrier Proteins | 2 | 2018 | 728 | 0.100 |
Why?
| | Magnetic Resonance Imaging | 2 | 2025 | 3917 | 0.100 |
Why?
| | Microsatellite Repeats | 3 | 2018 | 159 | 0.100 |
Why?
| | Cyclic GMP-Dependent Protein Kinase Type I | 1 | 2013 | 3 | 0.100 |
Why?
| | Transfer RNA Aminoacylation | 1 | 2013 | 2 | 0.100 |
Why?
| | Tetraspanins | 1 | 2013 | 19 | 0.100 |
Why?
| | Aging, Premature | 1 | 2013 | 18 | 0.100 |
Why?
| | Hair Cells, Auditory, Inner | 1 | 2013 | 17 | 0.100 |
Why?
| | Face | 1 | 2015 | 177 | 0.100 |
Why?
| | Leukoencephalopathies | 1 | 2013 | 23 | 0.100 |
Why?
| | Fatty Acids | 1 | 2016 | 460 | 0.100 |
Why?
| | Cytoplasm | 1 | 2014 | 253 | 0.100 |
Why?
| | Language Development Disorders | 1 | 2013 | 40 | 0.100 |
Why?
| | Biomarkers | 1 | 2024 | 4329 | 0.090 |
Why?
| | Cell Line | 1 | 2018 | 2809 | 0.090 |
Why?
| | Chickens | 1 | 2013 | 169 | 0.090 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2016 | 427 | 0.090 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2014 | 198 | 0.090 |
Why?
| | Neoplasm Proteins | 2 | 2017 | 443 | 0.090 |
Why?
| | Sequence Deletion | 1 | 2013 | 190 | 0.090 |
Why?
| | Computational Biology | 2 | 2018 | 675 | 0.090 |
Why?
| | GPI-Linked Proteins | 1 | 2012 | 81 | 0.090 |
Why?
| | Proteins | 1 | 2018 | 1021 | 0.090 |
Why?
| | Transforming Growth Factor beta2 | 1 | 2012 | 32 | 0.090 |
Why?
| | Claudins | 1 | 2012 | 23 | 0.090 |
Why?
| | Chromosomes, Human, Pair 7 | 1 | 2011 | 18 | 0.090 |
Why?
| | Smad3 Protein | 1 | 2011 | 41 | 0.090 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 2011 | 81 | 0.080 |
Why?
| | Population Surveillance | 1 | 2014 | 477 | 0.080 |
Why?
| | Chromosomes, Human, Pair 2 | 2 | 2013 | 27 | 0.080 |
Why?
| | Syndrome | 2 | 2015 | 377 | 0.080 |
Why?
| | Autoimmune Diseases | 1 | 2015 | 466 | 0.080 |
Why?
| | Aorta, Thoracic | 1 | 2013 | 284 | 0.080 |
Why?
| | Quality of Life | 1 | 2023 | 3187 | 0.080 |
Why?
| | Acyltransferases | 2 | 2023 | 78 | 0.080 |
Why?
| | Retrospective Studies | 2 | 2025 | 17291 | 0.080 |
Why?
| | Gene Expression Regulation | 1 | 2019 | 2591 | 0.080 |
Why?
| | Mitochondria | 1 | 2016 | 996 | 0.080 |
Why?
| | Heterozygote | 2 | 2014 | 310 | 0.070 |
Why?
| | Epilepsy | 1 | 2014 | 397 | 0.070 |
Why?
| | Software | 1 | 2014 | 673 | 0.070 |
Why?
| | DNA Mutational Analysis | 3 | 2017 | 409 | 0.070 |
Why?
| | Lung Diseases, Interstitial | 1 | 2015 | 677 | 0.070 |
Why?
| | Audiometry | 2 | 2005 | 34 | 0.070 |
Why?
| | Signal Transduction | 2 | 2019 | 5234 | 0.070 |
Why?
| | Protein Domains | 2 | 2021 | 314 | 0.060 |
Why?
| | Chromosomes, Human, Pair 20 | 1 | 2006 | 17 | 0.060 |
Why?
| | Chromosomes, Human, Pair 12 | 1 | 2006 | 22 | 0.060 |
Why?
| | Audiometry, Pure-Tone | 1 | 2006 | 25 | 0.060 |
Why?
| | Kelch-Like ECH-Associated Protein 1 | 1 | 2006 | 15 | 0.060 |
Why?
| | Jordan | 1 | 2005 | 5 | 0.060 |
Why?
| | Auditory Threshold | 1 | 2006 | 47 | 0.060 |
Why?
| | Sequence Analysis, Protein | 1 | 2005 | 32 | 0.060 |
Why?
| | Chromosome Aberrations | 1 | 2006 | 167 | 0.060 |
Why?
| | Population Dynamics | 1 | 2006 | 142 | 0.050 |
Why?
| | Chromosomes, Human, Pair 3 | 1 | 2005 | 43 | 0.050 |
Why?
| | Risk Factors | 2 | 2016 | 10840 | 0.050 |
Why?
| | Netherlands | 1 | 2005 | 84 | 0.050 |
Why?
| | Conserved Sequence | 1 | 2005 | 242 | 0.050 |
Why?
| | Linear Models | 1 | 2006 | 847 | 0.050 |
Why?
| | Hypopituitarism | 1 | 2023 | 16 | 0.050 |
Why?
| | Membrane Glycoproteins | 1 | 2006 | 495 | 0.050 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2020 | 899 | 0.050 |
Why?
| | Nuclear Proteins | 2 | 2018 | 739 | 0.050 |
Why?
| | Genome-Wide Association Study | 3 | 2016 | 1526 | 0.050 |
Why?
| | Calcium-Binding Proteins | 2 | 2014 | 219 | 0.040 |
Why?
| | United States | 1 | 2019 | 16041 | 0.040 |
Why?
| | Evolution, Molecular | 1 | 2005 | 501 | 0.040 |
Why?
| | Sex Characteristics | 1 | 2006 | 798 | 0.040 |
Why?
| | Sequence Homology | 1 | 2020 | 42 | 0.040 |
Why?
| | Fibroblasts | 2 | 2016 | 1033 | 0.040 |
Why?
| | Growth Disorders | 1 | 2020 | 88 | 0.040 |
Why?
| | Movement Disorders | 1 | 2020 | 68 | 0.040 |
Why?
| | Embryonic Development | 1 | 2020 | 124 | 0.040 |
Why?
| | Aged | 4 | 2016 | 26251 | 0.040 |
Why?
| | Nucleotide Mapping | 1 | 2018 | 3 | 0.040 |
Why?
| | Ophthalmoscopy | 1 | 2018 | 38 | 0.030 |
Why?
| | Cells, Cultured | 2 | 2016 | 4112 | 0.030 |
Why?
| | Disease Progression | 1 | 2006 | 2857 | 0.030 |
Why?
| | Sjogren-Larsson Syndrome | 1 | 2017 | 1 | 0.030 |
Why?
| | Ichthyosis Vulgaris | 1 | 2017 | 1 | 0.030 |
Why?
| | Porphyria, Variegate | 1 | 2017 | 1 | 0.030 |
Why?
| | Protoporphyrinogen Oxidase | 1 | 2017 | 1 | 0.030 |
Why?
| | Flavoproteins | 1 | 2017 | 8 | 0.030 |
Why?
| | Photosensitivity Disorders | 1 | 2017 | 8 | 0.030 |
Why?
| | 1-Acylglycerol-3-Phosphate O-Acyltransferase | 1 | 2017 | 3 | 0.030 |
Why?
| | Keratin-14 | 1 | 2017 | 9 | 0.030 |
Why?
| | INDEL Mutation | 1 | 2017 | 21 | 0.030 |
Why?
| | Xeroderma Pigmentosum | 1 | 2017 | 9 | 0.030 |
Why?
| | Epidermolysis Bullosa Simplex | 1 | 2017 | 10 | 0.030 |
Why?
| | Aldehyde Oxidoreductases | 1 | 2017 | 27 | 0.030 |
Why?
| | Intermediate Filament Proteins | 1 | 2017 | 34 | 0.030 |
Why?
| | Endonucleases | 1 | 2017 | 34 | 0.030 |
Why?
| | Collagen Type VII | 1 | 2017 | 25 | 0.030 |
Why?
| | Lipid Metabolism, Inborn Errors | 1 | 2017 | 20 | 0.030 |
Why?
| | Molecular Docking Simulation | 1 | 2018 | 120 | 0.030 |
Why?
| | Blister | 1 | 2017 | 38 | 0.030 |
Why?
| | Epidermolysis Bullosa Dystrophica | 1 | 2017 | 40 | 0.030 |
Why?
| | DNA-Binding Proteins | 2 | 2017 | 1467 | 0.030 |
Why?
| | Periodontal Diseases | 1 | 2017 | 62 | 0.030 |
Why?
| | Muscular Diseases | 1 | 2017 | 110 | 0.030 |
Why?
| | Genetic Complementation Test | 1 | 2016 | 72 | 0.030 |
Why?
| | Epidermolysis Bullosa | 1 | 2017 | 69 | 0.030 |
Why?
| | Stereocilia | 1 | 2016 | 9 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2005 | 2910 | 0.030 |
Why?
| | Cameroon | 1 | 2016 | 8 | 0.030 |
Why?
| | Transcription Factors | 2 | 2017 | 1728 | 0.030 |
Why?
| | Physical Chromosome Mapping | 2 | 2006 | 21 | 0.030 |
Why?
| | Basal Ganglia | 1 | 2016 | 60 | 0.030 |
Why?
| | Phospholipases | 1 | 2015 | 14 | 0.030 |
Why?
| | RNA, Messenger | 2 | 2014 | 2783 | 0.030 |
Why?
| | Chromosomes, Human, Pair 14 | 1 | 2015 | 23 | 0.030 |
Why?
| | Chromosomes, Human, Pair 17 | 1 | 2015 | 54 | 0.030 |
Why?
| | Mitochondrial Diseases | 1 | 2016 | 94 | 0.030 |
Why?
| | Adipokines | 1 | 2016 | 56 | 0.030 |
Why?
| | Cataract | 1 | 2018 | 238 | 0.030 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2016 | 104 | 0.030 |
Why?
| | Mitochondrial Proteins | 1 | 2017 | 263 | 0.030 |
Why?
| | Craniofacial Dysostosis | 1 | 2015 | 3 | 0.030 |
Why?
| | Follow-Up Studies | 1 | 2005 | 5397 | 0.030 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2015 | 382 | 0.030 |
Why?
| | Limit of Detection | 1 | 2015 | 92 | 0.030 |
Why?
| | Genotyping Techniques | 1 | 2015 | 72 | 0.030 |
Why?
| | Cloning, Molecular | 1 | 2016 | 526 | 0.030 |
Why?
| | Introns | 1 | 2016 | 257 | 0.030 |
Why?
| | Hepatocyte Growth Factor | 1 | 2014 | 33 | 0.030 |
Why?
| | Gene Rearrangement | 1 | 2015 | 155 | 0.030 |
Why?
| | Ion Channels | 1 | 2015 | 128 | 0.030 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2015 | 120 | 0.030 |
Why?
| | Alternative Splicing | 1 | 2016 | 249 | 0.030 |
Why?
| | Sample Size | 1 | 2014 | 123 | 0.020 |
Why?
| | Vascular Remodeling | 1 | 2016 | 208 | 0.020 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2016 | 271 | 0.020 |
Why?
| | Adenosine Triphosphatases | 1 | 2014 | 158 | 0.020 |
Why?
| | GTPase-Activating Proteins | 1 | 2014 | 81 | 0.020 |
Why?
| | Odds Ratio | 1 | 2016 | 1070 | 0.020 |
Why?
| | Myosin Light Chains | 1 | 2013 | 28 | 0.020 |
Why?
| | Protein Transport | 1 | 2015 | 439 | 0.020 |
Why?
| | Cyclic GMP | 1 | 2013 | 88 | 0.020 |
Why?
| | Disease | 1 | 2014 | 97 | 0.020 |
Why?
| | Heart Valve Diseases | 1 | 2014 | 150 | 0.020 |
Why?
| | Osteogenesis | 1 | 2015 | 204 | 0.020 |
Why?
| | Endoplasmic Reticulum | 1 | 2015 | 268 | 0.020 |
Why?
| | Aorta | 1 | 2016 | 440 | 0.020 |
Why?
| | Retina | 1 | 2015 | 330 | 0.020 |
Why?
| | Genome, Human | 1 | 2014 | 425 | 0.020 |
Why?
| | Data Interpretation, Statistical | 1 | 2014 | 365 | 0.020 |
Why?
| | Haploinsufficiency | 1 | 2012 | 53 | 0.020 |
Why?
| | Saccharomyces cerevisiae | 1 | 2016 | 584 | 0.020 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2016 | 530 | 0.020 |
Why?
| | Ribose-Phosphate Pyrophosphokinase | 1 | 2011 | 1 | 0.020 |
Why?
| | Aortic Valve | 1 | 2014 | 360 | 0.020 |
Why?
| | Age of Onset | 1 | 2013 | 557 | 0.020 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2011 | 56 | 0.020 |
Why?
| | Neuropeptides | 1 | 2011 | 75 | 0.020 |
Why?
| | Chromosomes, Human, Pair 21 | 1 | 2011 | 43 | 0.020 |
Why?
| | Models, Genetic | 1 | 2013 | 537 | 0.020 |
Why?
| | Gene Expression | 1 | 2016 | 1461 | 0.020 |
Why?
| | Muscle Contraction | 1 | 2013 | 427 | 0.020 |
Why?
| | Glycoproteins | 1 | 2011 | 355 | 0.020 |
Why?
| | Computer Simulation | 1 | 2013 | 1014 | 0.020 |
Why?
| | Trans-Activators | 1 | 2011 | 371 | 0.020 |
Why?
| | Actins | 1 | 2011 | 422 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2011 | 834 | 0.020 |
Why?
| | Apoptosis | 1 | 2016 | 2436 | 0.020 |
Why?
| | Cell Cycle Proteins | 1 | 2011 | 629 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2011 | 1236 | 0.020 |
Why?
| | India | 1 | 2006 | 213 | 0.010 |
Why?
| | Brain | 1 | 2013 | 2981 | 0.010 |
Why?
|
|
Santos-Cortez's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|